| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/04/2010 | US20100029719 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/04/2010 | US20100029710 COMPOUNDS HAVING BOTH ANGIOTENSIN II RECEPTOR ANTAGONISM AND PPARy ACTIVATING ACTIVITIES |
| 02/04/2010 | US20100029709 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 02/04/2010 | US20100029680 Certain Chemical Entities, Compositions and Methods |
| 02/04/2010 | US20100029678 Diuretics |
| 02/04/2010 | US20100029675 Pyrimidine-2, 4-diamine JAK2 Kinase inhibiting anti-inflammation use |
| 02/04/2010 | US20100029673 Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use |
| 02/04/2010 | US20100029662 Vasoconstriction compositions and methods of use |
| 02/04/2010 | US20100029661 Anesthetic compositions and methods of use |
| 02/04/2010 | US20100029660 Compositions and methods for reversing rebound hyperemia |
| 02/04/2010 | US20100029659 Preferential vasoconstriction compositions and methods of use |
| 02/04/2010 | US20100029654 Cardiovascular compositions and use of the same for the treatment of alzheimer's disease |
| 02/04/2010 | US20100029653 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders |
| 02/04/2010 | US20100029639 Ion channel modulating compounds and uses thereof |
| 02/04/2010 | US20100029637 Chymase Inhibitors |
| 02/04/2010 | US20100029631 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 02/04/2010 | US20100029628 2,4,5-Substituted Piperidines as Renin Inhibitors |
| 02/04/2010 | US20100029627 Mtki quinazoline derivatives |
| 02/04/2010 | US20100029625 Therapeutic Agent for Restenosis |
| 02/04/2010 | US20100029621 Hexafluoroisopropanol derivatives |
| 02/04/2010 | US20100029616 Urotensin ii receptor antagonists |
| 02/04/2010 | US20100029600 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 02/04/2010 | US20100029599 Indolylamides as modulators of the EP2 receptor |
| 02/04/2010 | US20100029589 4,5-dihydro-oxazol-2yl derivatives |
| 02/04/2010 | US20100029578 Methods of Treating Atrial Fibrillation with P38 Inhibitor Compounds |
| 02/04/2010 | US20100029577 Chiral separation, characterization and biological action of optically active isomers of digoxin |
| 02/04/2010 | US20100029562 hG31P Expression System |
| 02/04/2010 | US20100029554 Composition and Methods for Treatment of Congestive Heart Failure |
| 02/04/2010 | US20100029552 Peptide inhibitors of c-jun dimerization and uses thereof |
| 02/04/2010 | US20100028905 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 02/04/2010 | US20100028439 Nanoparticulate stabilized anti-hypertensive compositions |
| 02/04/2010 | US20100028429 Salts of potassium atp channel openers and uses thereof |
| 02/04/2010 | US20100028422 Pharmaceutical Compositions and Methods for Treating or Preventing Oxalate-Related Disease |
| 02/04/2010 | US20100028401 Stem cell source for promoting neovascularisation |
| 02/04/2010 | US20100028364 Inhibition of sox9 function in the treatment of proteoglycan-associated pathophysiological conditions |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028327 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/04/2010 | US20100028315 Dried and/or microencapsulated saccharomyces cerevisiae cells with a high content of (s)-(+)-s-adenosyl-l-methionine, process for their preparation, and compositons containing said cells |
| 02/04/2010 | US20100028311 Using of scaffold comprising fibrin for delivery of stem cells |
| 02/04/2010 | CA2738510A1 6-substituted isoflavonoid compounds and uses thereof |
| 02/04/2010 | CA2733077A1 Composition for prophylaxis or treatment of hyperlipidemia, fatty liver or obesity |
| 02/04/2010 | CA2732763A1 Methods for treating reperfusion injuries |
| 02/04/2010 | CA2732632A1 Psma-binding agents and uses thereof |
| 02/04/2010 | CA2732513A1 Methods and compositions involving (s)-bucindolol |
| 02/04/2010 | CA2732018A1 Solid pharmaceutical composition |
| 02/04/2010 | CA2731957A1 Nitro derivatives of furasemide and their use as diuretics |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/04/2010 | CA2730770A1 Diazepan and piperazine derivatives modulators of chemokine receptors |
| 02/04/2010 | CA2730659A1 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 02/04/2010 | CA2728096A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 02/03/2010 | EP2149576A1 Isosorbide Nitrates having vasodilating activity |
| 02/03/2010 | EP2149563A1 Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound |
| 02/03/2010 | EP2149560A1 1-substituted tetrahydroisoquinoline compound |
| 02/03/2010 | EP2149373A1 5HT7 receptor ligands and compositions comprising the same |
| 02/03/2010 | EP2148871A1 Quinoline-carboxamide derivatives as p2y12 antagonists |
| 02/03/2010 | EP2148672A1 Oxazolidinone for the treatment and prophylaxis of pulmonary hypertension |
| 02/03/2010 | CN201393824Y Multifunctional healthcare pillow |
| 02/03/2010 | CN101638437A Growth hormone fusion protein |
| 02/03/2010 | CN101637624A Medical devices containing rapamycin analogs |
| 02/03/2010 | CN100586444C Method of processing ginseng for medicinal use and composition |
| 02/03/2010 | CN100586425C Cinnamon poria capsule and its preparation process |
| 02/02/2010 | US7655780 Integrin-linked kinase and its uses |
| 02/02/2010 | US7655694 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655637 N-pyrazole A2A receptor agonists |
| 02/02/2010 | US7655633 Beta-D-Glucopyranosyloxy)-3-(3-fluoro-4-methylbenzyl)-4,6-dimethylpyridine; sodium glucose co-transporter 2 (SGLT2) inhibitors; excellent hypoglycemic effect by excreting excess glucose into the urine through preventing the reabsorption of glucose at the kidney; antidiabetic agents; hyperglycemia |
| 02/02/2010 | US7655632 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 02/02/2010 | US7655628 Method for treating liver cirrhosis or interstitial pulmonary fibrosis |
| 02/02/2010 | US7655624 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 02/02/2010 | US7655616 Traumatic brain and spinal cord injury treatment; administering interleukin-1B converting enzyme (capsase-1) inhibitor |
| 02/02/2010 | US7655463 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 02/02/2010 | US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES |
| 02/02/2010 | US7655415 Interleukin 1 Receptor-Like 1 (IL1RL-1); cardiovascular conditions including cardiac hypertrophy, myocardial infarction, stroke, arteriosclerosis, and heart failure |
| 02/02/2010 | US7655251 Amphiphilicmonocatenary glycosylated hydrocarbon nitrones; oxidation resistance;free radical scavengers; neuroprotectants; cosmetic products for the skin, hair andnails; imunotherapy; antiinflammatory agents; Alzheimer's disease; Parkinson'sdisease; aging resistance; radiation injuries |
| 02/02/2010 | US7655226 Treatment of Pompe's disease |
| 02/02/2010 | US7654957 Apparatus for physical measurements of the eye |
| 02/02/2010 | CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/02/2010 | CA2454830C Substituted urea neuropeptide y y5 receptor antagonists |
| 02/02/2010 | CA2410305C Preparations comprising combinations of enzyme inhibitors, and the use thereof |
| 02/02/2010 | CA2401832C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 02/02/2010 | CA2396158C Dipeptide nitrile cathepsin k inhibitors |
| 02/02/2010 | CA2383412C Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 02/02/2010 | CA2358581C Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 02/02/2010 | CA2316172C Indole derivatives as inhibitors of factor xa |
| 02/02/2010 | CA2315205C Substituted 2-aryl-4-amino-quinazolines, methods for the prodution ans use thereof as medicaments |
| 01/28/2010 | WO2010011868A2 Pyridine sulfonamide modulators of endothelin-a-receptor |
| 01/28/2010 | WO2010011821A2 Dual-acting antihypertensive agents |
| 01/28/2010 | WO2010011349A2 Pyrimidine-2,4-diamine jak2 kinase inhibiting anti-inflammation use |
| 01/28/2010 | WO2010011331A2 Compositions and methods related to sirt1 function |
| 01/28/2010 | WO2010011319A2 Magnetic heating for drug delivery and other applications |
| 01/28/2010 | WO2010010949A1 Lipase inhibitor |
| 01/28/2010 | WO2010010288A2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 01/28/2010 | WO2010010141A1 Pramipexole for treating cardiomyopathy |
| 01/28/2010 | WO2010010112A2 Construct and method for the internalization of cargo molecules into a cell |
| 01/28/2010 | WO2010010101A1 Isosorbide nitrates having vasodilating activity |
| 01/28/2010 | WO2010009619A1 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 01/28/2010 | WO2010009618A1 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 01/28/2010 | WO2010009589A1 Use of hydrochloric acid for the manufacture of a medicament for treatment of gastritis, enteritis and angiitis |
| 01/28/2010 | WO2010009573A1 A pharmaceutical composition for regulating the potassium channel in cardiac muscle cell and its preparation method and its uses |